TMEM64 and hepatocellular carcinoma: The CTD Gene–Disease Associations dataset shows that TMEM64 is associated with liver diseases (standardized value, SV = 1.45), drug-induced liver injury (SV = 1.59), fatty liver (SV = 1.04), liver neoplasms (SV = 1.34), hepatocellular carcinoma (SV = 1.27), and acute liver failure (SV = 1.03), suggesting its potential involvement in hepatic pathology.